Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial ; volume:14 ; number:1 ; day:11 ; month:11 ; year:2023 ; pages:1-12 ; date:12.2023
Nature Communications ; 14, Heft 1 (11.11.2023), 1-12, 12.2023
- Urheber
-
Lim, Sun Min
Peters, Solange
Ortega Granados, Ana Laura
Pinto, Gustavo dix Junqueira
Fuentes, Christian Sebastián
Lo Russo, Giuseppe
Schenker, Michael
Ahn, Jin Seok
Reck, Martin
Szijgyarto, Zsolt
Huseinovic, Neda
Zografos, Eleftherios
Buss, Elena
Stjepanovic, Neda
O’Donnell, Sean
Marinis, Filippo de
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-42900-4
- URN
-
urn:nbn:de:101:1-2024013013010840357060
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lim, Sun Min
- Peters, Solange
- Ortega Granados, Ana Laura
- Pinto, Gustavo dix Junqueira
- Fuentes, Christian Sebastián
- Lo Russo, Giuseppe
- Schenker, Michael
- Ahn, Jin Seok
- Reck, Martin
- Szijgyarto, Zsolt
- Huseinovic, Neda
- Zografos, Eleftherios
- Buss, Elena
- Stjepanovic, Neda
- O’Donnell, Sean
- Marinis, Filippo de
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer
Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas
Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
Role of inflammation in previously untreated macular edema with branch retinal vein occlusion
Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
P1.14 PWV Improvement in Previously Untreated Mild Hypertensive Patients After 1 Year of Monotherapy
Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy
Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial
Pembrolizumab
Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer
Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas
Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
Role of inflammation in previously untreated macular edema with branch retinal vein occlusion
Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
P1.14 PWV Improvement in Previously Untreated Mild Hypertensive Patients After 1 Year of Monotherapy
Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy
Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial
Pembrolizumab
Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer
Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas
Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
Role of inflammation in previously untreated macular edema with branch retinal vein occlusion
Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
P1.14 PWV Improvement in Previously Untreated Mild Hypertensive Patients After 1 Year of Monotherapy
Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy
Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial